Kissei Pharmaceutical (OTCMKTS:KSPHF – Get Free Report) is expected to be announcing its resultson Friday, July 31st. Analysts expect Kissei Pharmaceutical to post earnings of $0.3941 per share and revenue of $136.7230 million for the quarter.
Kissei Pharmaceutical Price Performance
Kissei Pharmaceutical stock opened at $25.77 on Friday. The firm has a 50 day moving average of $25.77 and a 200 day moving average of $26.18. Kissei Pharmaceutical has a 12-month low of $23.23 and a 12-month high of $31.90.
Kissei Pharmaceutical Company Profile
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.
The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.
Featured Articles
- Five stocks we like better than Kissei Pharmaceutical
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
